About the conference
This is a two day conference for early-career researchers. Participants will be selected based on their submitted abstract. The conference is free of charge and includes meals and an overnight stay at the conference location, Marienlyst Strandhotel.
The conference is organized by ReproYoung – a network of early-career researchers in Reproductive Medicine based in Copenhagen, Denmark and in Lund, Sweden.
The speakers of the conference will be a combination of national and international senior researchers, as well as younger researchers. It is therefore a good opportunity for networking.
Guidelines for Abstract submission:
The conference is designed to provide an open space for early-career researchers to share their work, practice presentation skills, and network. To ensure active participation, the conference is free of charge, with the only requirement being the submission of a research abstract. All participants will contribute either through a short oral presentation or by taking part in the poster walks and present their own poster.
- Submission deadline 1st of December 2025
- Abstracts must be submitted in English and have a maximum number of 2000 characters (~300 words)
- The conference is aimed at researchers in the early stages of their careers. If spots are limited, priority will be given to PhD students and postdoctoral researchers, but everyone is welcome to send an abstract incl. students.
- Data included in the abstracts should not have been previously published, or if published, the publication date must be within the last year.
- The presenting author should be the first name in the author list.
- Structure: Abstracts should be structured as follows.
- Background – Brief context and aim of the study.
- Methods – Outline of methodology or approach.
- Results – Key findings (include data if available, abstract with not results are also accepted).
- Conclusion – Main message and relevance.
The ReproYoung Members will select participants based on their abstracts.
The conference is supported by the Novo Nordisk Foundation and ReproUnion.